Delivery Order SPE2DE24D0021-SPE2D626F9328
- Not listed
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $2,940 on January 8, 2026, for BinaxNOW COVID-19 antigen testing kits to support the Defense Department's Medical Supply Chain. The contract is a fixed-price delivery order with economic price adjustment provisions, with a completion deadline of January 15, 2026. As a child contract, this award represents an individual order issued under a larger indefinite delivery vehicle or blanket purchase agreement. No set-aside...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order valued at $2,156 to Fisher Scientific Company L.L.C. on November 20, 2025, for the provision of BinaxNOW COVID-19 antigen testing kits. This is a fixed-price delivery order with economic price adjustment provisions, with an ultimate completion date of November 28, 2025. The contract carries no set-aside designation, indicating Fisher Scientific competed for this award in an open procurement environment. Performance will...
- Fisher Scientific Company L.L.C. has been awarded a $4.3K delivery order for BinaxNOW COVID-19 antigen testing kits under a fixed-price contract with economic price adjustment provisions. The award was issued on January 7, 2026, with an ultimate completion date of January 14, 2026, and will be performed in Pittsburgh, Pennsylvania. This delivery order was issued without a set-aside designation, indicating open competition, and is funded by the Department of Defense's Medical Supply Chain...
- Fisher Scientific Company L.L.C. was awarded a delivery order contract for BinaxNow COVID-19 antigen testing kits on September 16, 2025, with a ceiling value of $1,960. The contract, issued by the Defense Medical Supply Chain, is structured as a fixed-price delivery order with economic price adjustment provisions and carries no set-aside designation, reflecting open competition in the award process. Performance will be executed in Pittsburgh, Pennsylvania, with an ultimate completion date of...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,076.64 on August 21, 2025, for the procurement of BinaxNow COVID-19 antigen testing kits. The contract is structured as a fixed-price delivery order with economic price adjustment provisions and is funded by the Defense Department's Medical Supply Chain division. Performance will be completed in Pittsburgh, Pennsylvania, with an ultimate completion date of August 28, 2025. This award represents a child contract with no...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,176.00 by the Department of Defense's Medical Supply Chain for the provision of BinaxNOW COVID-19 antigen testing kits. The contract was awarded on October 30, 2025, with an ultimate completion date of November 6, 2025, and will be performed in Pittsburgh, Pennsylvania. This delivery order represents a fixed-price contract with economic price adjustment provisions and was issued without set-aside designations,...
- Fisher Scientific Company L.L.C. received a delivery order award on August 22, 2025, for the procurement of BinaxNOW COVID-19 antigen testing kits. The contract carries a ceiling value of $2,213.20 and is structured as a fixed-price agreement with economic price adjustment provisions. Funding originates from the Medical Supply Chain division within the Department of Defense. The place of performance is listed as Pittsburgh, PA. This delivery order represents a child contract, indicating it falls...
- Fisher Scientific Company L.L.C. received a delivery order award valued at $1,339.82 from the Department of Defense's Medical Supply Chain on December 4, 2025, for BINAXNOW COVID-19 Antigen OTC test kits (12 tests per box, case quantity). This fixed-price delivery order with economic price adjustment is expected to be completed by December 11, 2025, and will be performed in Pittsburgh, Pennsylvania. The award was made without a set-aside designation, indicating open competition. This delivery...
- Fisher Scientific Company L.L.C. has been awarded a delivery order valued at $2,205.00 for BinaxNow COVID-19 antigen OTC test kits (12 tests per 2-test case) by the Defense Medical Supply Chain federal agency. The contract, awarded on September 9, 2025, with an ultimate completion date of September 16, 2025, utilizes a fixed price with economic price adjustment pricing structure. The place of performance is Pittsburgh, Pennsylvania. This delivery order represents a child contract, indicating...
- Fisher Scientific Company L.L.C. was awarded a delivery order valued at $2,897.80 on August 11, 2025, for the provision of BinaxNOW COVID antigen testing kits to support the Medical Supply Chain, a defense-oriented federal agency. This fixed-price delivery order with economic price adjustment capability represents a child contract under a larger vehicle and will be performed in Pittsburgh, Pennsylvania, with an ultimate completion date of August 18, 2025. No set-aside designation was applied...
- SPE2DE24D0021Indefinite Delivery Contract
- SPE2DE24D0021-SPE2D626F9328Delivery Order
Fisher Scientific Company L.L.C. was awarded a delivery order valued at $1,159.12 on November 4, 2025, for the provision of BinaxNow COVID antigen testing kits to support the Department of Defense Medical Supply Chain. The contract is structured as a fixed-price delivery order with economic price adjustment provisions and carries an ultimate completion date of November 12, 2025. Performance will be executed from Fisher Scientific's location in Pittsburgh, Pennsylvania. This award represents a child contract issued under a larger procurement vehicle and was not designated as a set-aside contract, indicating competition in an open federal procurement environment. Fisher Scientific, a major federal vendor specializing in scientific products, laboratory equipment, and medical supplies, has an established track record serving federal agencies including the Department of Veterans Affairs, Department of Defense, and various civilian health institutes. The company's extensive portfolio demonstrates consistent capability in delivering specialized diagnostic equipment and reagents supporting healthcare delivery and diagnostic operations across the federal government. This COVID testing kit delivery order aligns with the company's core competencies in providing diagnostic solutions to federal health and defense agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 11/4/25 |